Alpha 1-antitrypsin deficiency synonyms

Alpha-1 antitrypsin deficiency (AATD) is a rare genetic disorder characterized by a lack of the AAT protein, which protects the lungs from inflammation and damage. It is also commonly referred to as AAT deficiency, Alpha-1, or hereditary emphysema, and it is categorized in medical databases under terms reflecting its protein-based origin or clinical manifestations.

What are the common names and synonyms for Alpha-1 antitrypsin deficiency?

While Alpha-1 antitrypsin deficiency is the standard clinical term used by physicians and researchers today, you may encounter several synonyms in medical records or historical literature. Common abbreviations include AATD, AAT deficiency, and Alpha-1. Historically, the condition has been referred to as Pi (protease inhibitor) deficiency, reflecting the genetic nomenclature system used to classify the variants of the protein. In some older clinical texts, you might see it labeled as hereditary emphysema or hereditary panlobular emphysema, terms that describe the primary pulmonary impact of the disease rather than the genetic cause.

How is the condition classified in official medical systems?

Standardized nomenclature is vital for global medical communication. In official classification systems, Alpha-1 antitrypsin deficiency is recognized as follows:

• Orphanet: Listed under ORPHA:60 (Alpha-1 antitrypsin deficiency).


• OMIM (Online Mendelian Inheritance in Man): Identified by entry #613490 (SERPINA1 gene).


• ICD-10/11: Coded as E88.01, ensuring consistent billing and clinical documentation across healthcare systems worldwide.

Why does Alpha-1 antitrypsin deficiency have so many different names?

The existence of multiple names for Alpha-1 antitrypsin deficiency is primarily due to the evolution of medical diagnostics. When the condition was first described in 1963 by Laurell and Eriksson, it was identified by its association with early-onset emphysema. As our understanding of the SERPINA1 gene and the protease inhibitor (Pi) system improved, the naming shifted from descriptive (based on symptoms like emphysema) to biochemical (based on the deficient protein). Today, medical professionals prefer Alpha-1 antitrypsin deficiency because it precisely identifies the specific protein deficiency, allowing for more accurate diagnosis and targeted therapeutic approaches.

What are the key clinical identifiers for this condition?

Understanding the terminology is a critical first step for the 339 members of the DiseaseMaps.org community who are managing this condition. Whether labeled as Alpha-1 antitrypsin deficiency or AATD, the clinical reality remains the same: a significant reduction in the protective protein leads to lung and liver complications. Because the condition is often underdiagnosed, patients may see these various synonyms appear as they transition between specialists, such as pulmonologists or hepatologists.

Next steps

• Consult a genetic counselor to understand your specific "Pi" genotype (e.g., PiZZ, PiSZ).


• Connect with the 339 members of the Alpha-1 antitrypsin deficiency community at DiseaseMaps.org to share experiences and coping strategies.


• Request a copy of your full lab results to see how your specific diagnosis is coded in your electronic health record.


• Monitor for updates on clinical trials and research by visiting the Alpha-1 Foundation website.

Medical disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• NIH Genetic and Rare Diseases (GARD) Information Center: Alpha-1 antitrypsin deficiency.


• Orphanet: Alpha-1 antitrypsin deficiency (ORPHA:60).


• OMIM: SERPINA1 Gene (MIM #613490).


• Alpha-1 Foundation: Understanding Alpha-1.